Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national
4
×
national blog main
national top stories
new york blog main
san francisco blog main
biotech
clinical trials
new york top stories
san francisco top stories
alnylam pharmaceuticals
autoimmune diseases
biotech ipos
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
europe blog main
europe top stories
fda
immunotherapy
indiana blog main
indiana top stories
investing
medicare
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
spark therapeutics
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
What
market
4
×
drug
new
patients
payers
science
advantages
aren’t
arrival
bar
bio
biotech
brings
cancer
car
companies
cutting
days
edge
eisai
expect
experiments
fda
flags
gamble
gene
hasn’t
higher
hot
incidence
industry
interference
ipo
ipos
launch
life
lorcaserin
loss
marketing
medco’s
Language
unset
Current search:
market
×
national
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”
